These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 18356290)
1. Semaphorin 3B is a 1,25-Dihydroxyvitamin D3-induced gene in osteoblasts that promotes osteoclastogenesis and induces osteopenia in mice. Sutton AL; Zhang X; Dowd DR; Kharode YP; Komm BS; Macdonald PN Mol Endocrinol; 2008 Jun; 22(6):1370-81. PubMed ID: 18356290 [TBL] [Abstract][Full Text] [Related]
2. Class 3 semaphorins are transcriptionally regulated by 1,25(OH) Ryynänen J; Kriebitzsch C; Meyer MB; Janssens I; Pike JW; Verlinden L; Verstuyf A J Steroid Biochem Mol Biol; 2017 Oct; 173():185-193. PubMed ID: 28189595 [TBL] [Abstract][Full Text] [Related]
3. Effects of geranylgeranoic acid in bone: induction of osteoblast differentiation and inhibition of osteoclast formation. Wang X; Wu J; Shidoji Y; Muto Y; Ohishi N; Yagi K; Ikegami S; Shinki T; Udagawa N; Suda T; Ishimi Y J Bone Miner Res; 2002 Jan; 17(1):91-100. PubMed ID: 11771673 [TBL] [Abstract][Full Text] [Related]
4. 1,25(OH)2 vitamin D3-stimulated osteoclast formation in spleen-osteoblast cocultures is mediated in part by enhanced IL-1 alpha and receptor activator of NF-kappa B ligand production in osteoblasts. Lee SK; Kalinowski J; Jastrzebski S; Lorenzo JA J Immunol; 2002 Sep; 169(5):2374-80. PubMed ID: 12193704 [TBL] [Abstract][Full Text] [Related]
5. Neuropilin 2 in osteoblasts regulates trabecular bone mass in male mice. Verlinden L; Doms S; Janssens I; Meyer MB; Pike JW; Carmeliet G; Verstuyf A Front Endocrinol (Lausanne); 2023; 14():1223021. PubMed ID: 37600714 [TBL] [Abstract][Full Text] [Related]
6. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse. Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637 [TBL] [Abstract][Full Text] [Related]
7. Progesterone and 1,25-dihydroxyvitamin D₃ inhibit endometrial cancer cell growth by upregulating semaphorin 3B and semaphorin 3F. Nguyen H; Ivanova VS; Kavandi L; Rodriguez GC; Maxwell GL; Syed V Mol Cancer Res; 2011 Nov; 9(11):1479-92. PubMed ID: 21933904 [TBL] [Abstract][Full Text] [Related]
8. Downregulation of Runx2 by 1,25-Dihydroxyvitamin D₃ Induces the Transdifferentiation of Osteoblasts to Adipocytes. Kim JH; Seong S; Kim K; Kim I; Jeong BC; Kim N Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27213351 [TBL] [Abstract][Full Text] [Related]
9. Kruppel-like factor 4 attenuates osteoblast formation, function, and cross talk with osteoclasts. Kim JH; Kim K; Youn BU; Lee J; Kim I; Shin HI; Akiyama H; Choi Y; Kim N J Cell Biol; 2014 Mar; 204(6):1063-74. PubMed ID: 24616223 [TBL] [Abstract][Full Text] [Related]
10. Bone morphogenetic protein 2 enhances mouse osteoclast differentiation via increased levels of receptor activator of NF-κB ligand expression in osteoblasts. Tachi K; Takami M; Zhao B; Mochizuki A; Yamada A; Miyamoto Y; Inoue T; Baba K; Kamijo R Cell Tissue Res; 2010 Nov; 342(2):213-20. PubMed ID: 20941510 [TBL] [Abstract][Full Text] [Related]
12. Effect of osteoblast-targeted expression of bcl-2 in bone: differential response in male and female mice. Pantschenko AG; Zhang W; Nahounou M; McCarthy MB; Stover ML; Lichtler AC; Clark SH; Gronowicz GA J Bone Miner Res; 2005 Aug; 20(8):1414-29. PubMed ID: 16007339 [TBL] [Abstract][Full Text] [Related]
13. Meningioma 1 is required for appropriate osteoblast proliferation, motility, differentiation, and function. Zhang X; Dowd DR; Moore MC; Kranenburg TA; Meester-Smoor MA; Zwarthoff EC; MacDonald PN J Biol Chem; 2009 Jul; 284(27):18174-83. PubMed ID: 19386590 [TBL] [Abstract][Full Text] [Related]
14. A potent analog of 1alpha,25-dihydroxyvitamin D3 selectively induces bone formation. Shevde NK; Plum LA; Clagett-Dame M; Yamamoto H; Pike JW; DeLuca HF Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13487-91. PubMed ID: 12374862 [TBL] [Abstract][Full Text] [Related]
15. Changing RANKL/OPG mRNA expression in differentiating murine primary osteoblasts. Thomas GP; Baker SU; Eisman JA; Gardiner EM J Endocrinol; 2001 Aug; 170(2):451-60. PubMed ID: 11479141 [TBL] [Abstract][Full Text] [Related]
16. Vitamin D receptor in osteoblasts is a negative regulator of bone mass control. Yamamoto Y; Yoshizawa T; Fukuda T; Shirode-Fukuda Y; Yu T; Sekine K; Sato T; Kawano H; Aihara K; Nakamichi Y; Watanabe T; Shindo M; Inoue K; Inoue E; Tsuji N; Hoshino M; Karsenty G; Metzger D; Chambon P; Kato S; Imai Y Endocrinology; 2013 Mar; 154(3):1008-20. PubMed ID: 23389957 [TBL] [Abstract][Full Text] [Related]
17. Vitamin D receptor in chondrocytes promotes osteoclastogenesis and regulates FGF23 production in osteoblasts. Masuyama R; Stockmans I; Torrekens S; Van Looveren R; Maes C; Carmeliet P; Bouillon R; Carmeliet G J Clin Invest; 2006 Dec; 116(12):3150-9. PubMed ID: 17099775 [TBL] [Abstract][Full Text] [Related]
18. Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free medium. Atkins GJ; Kostakis P; Welldon KJ; Vincent C; Findlay DM; Zannettino AC J Cell Physiol; 2005 Jun; 203(3):573-82. PubMed ID: 15573398 [TBL] [Abstract][Full Text] [Related]
19. Osteoblastic NF-κB pathway is involved in 1α, 25(OH)2D3-induced osteoclast-like cells formation in vitro. Cong L; Zhang C; Tu G Int J Clin Exp Pathol; 2015; 8(5):5988-96. PubMed ID: 26191332 [TBL] [Abstract][Full Text] [Related]
20. High dose 1,25(OH)2D3 inhibits osteoblast mineralization in vitro. Yamaguchi M; Weitzmann MN Int J Mol Med; 2012 May; 29(5):934-8. PubMed ID: 22307202 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]